| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 10.1K | $6.55K | $0.65 | Sep 3, 2022 | Direct |
| Acorda Therapeutics, Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 77.3K | Mar 31, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACOR | Acorda Therapeutics, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Commercial Officer |
| ACOR | ACORDA THERAPEUTICS INC | Sep 3, 2022 | 1 | -$601 | 4 | Sep 7, 2022 | Chief Commercial Officer |
| ACOR | ACORDA THERAPEUTICS INC | Sep 9, 2021 | 0 | $0 | 3/A | Sep 20, 2021 | Chief Commercial Officer |